Evidence map›Paper›PMID 36381059›Full record

ArticleClinical case reports2022

IVIG for refractory dysphagia in Antisynthetase syndrome: A truth hard to swallow.

Mais Alnoukari, Oziel Garza De La Garza, Karrar Al Gburi, Niral Patel, Henderson Lopez, Muhammad Shamim, Henry Kwang

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mais AlnoukariUniversity of Texas Rio Grande Health Sciences Department and Valley Baptist Medical Center Harlingen Texas USA.ORCID https://orcid.org/0000-0001-6097-9298
Oziel Garza De La GarzaUniversity of Texas Rio Grande Health Sciences Department and Valley Baptist Medical Center Harlingen Texas USA.
Karrar Al GburiUniversity of Texas Rio Grande Health Sciences Department and Valley Baptist Medical Center Harlingen Texas USA.
Niral PatelUniversity of Texas Rio Grande Health Sciences Department and Valley Baptist Medical Center Harlingen Texas USA.
Henderson LopezUniversity of Texas Rio Grande Health Sciences Department and Valley Baptist Medical Center Harlingen Texas USA.
Muhammad ShamimUniversity of Texas Rio Grande Health Sciences Department and Valley Baptist Medical Center Harlingen Texas USA.
Henry KwangUniversity of Texas Rio Grande Health Sciences Department and Valley Baptist Medical Center Harlingen Texas USA.
Valley Baptist Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Refractory dysphasia could be the main symptom of Antisynthetase syndrome (ASS). IVIG may have a major impact in the successful treatment of dysphasia in patients with ASS. In our patient with ASS, IVIG treatment was an unreplaceable treatment option, and the patient regains her ability to swallow within 2 days.

Indexed as

anti‐PL‐12 antibodyAntisynthetase syndromecase reportdysphasiainflammatory myopathyintravenous immunoglobulin

Identifiers

PMID36381059
PMCPMC9658378
OpenAlexW4309246138

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.